Aiming to enhance and broaden its technology and solution portfolio, Germany's Biomax Informatics AG has acquired the operative business of the Austrian data mining specialist eudaptics software gmbh.
This extends the Biomax offering with the "Viscovery" range of products. With its intuitive visual approach to data exploration, the Viscovery Suite ideally complements the knowledge management system offered by Biomax, the German firm says. This is especially important for areas such as biomarker identification and validation, toxicology and clinical research. Data mining products and solutions will be offered by Viscovery Software GmbH, a 100% subsidiary of Biomax.
Klaus Heumann, chief executive of Biomax, said: "with this acquisition, we can offer comprehensive solutions for the integrated analysis and interpretation of biological and clinical experimental data to our customers and thus strengthen our unique position in the market."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze